TransMedics Group, Inc. (TMDX)
TransMedics makes the Organ Care System, a portable device that keeps donor organs living outside the body for transplant. It last closed at $93.91 on Nov 17, up 1.84% on the day. The average 12-month price target from 6 analysts is $107.17 (+14.1% from the last close), with a high of $120.00 and a low of $85.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in TMDX, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints totaling $4.1M, the largest $1.8M.
Key Stats
Last 12 monthsNot reported for this period.
From TMDX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 6 analysts who set a price target on TMDX in the past 90 days. The average target is $107.17, with a high of $120.00 and a low of $85.00, compared with the last close of $93.91.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 9 | UBS | Target raised | Hold | $77 → $88 |
| Nov 7 | JP Morgan | Maintained | Hold | $85 |
| Nov 6 | Needham | Target lowered | Buy | $208 → $110 |
| Nov 6 | Canaccord Genuity | Target raised | Buy | $94 → $120 |
| Oct 13 | Canaccord Genuity | Maintained | Buy | $94 |
Technical Analysis
The stock is 17% above its 20 day and 14% above its 50 day average. It is 3% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), overbought. The nearest support is the Pivot at $93.61, and the nearest resistance the swing high (Aug 21) at $95.18.
| RSI (14) | 68.27 | Strong, overbought above 70 | Neutral |
| MACD | 4.43 | Above its signal line | Bullish |
| Stochastic | 84.7 | Near the top of its range | Overbought |
| ADX (14) | 38.1 | Trending up | |
| Williams %R | -11.1 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 97.0 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +39.5% | Change over 10 sessions | Bullish |
| ATR (14) | $4.99 | Typical daily range, 5.3% of price |
| RSI (14) | 55.87 | Middle of its range | Neutral |
| MACD | -1.99 | Above its signal line | Bullish |
| Stochastic | 82.5 | Near the top of its range | Overbought |
| ADX (14) | 14.0 | No clear trend | |
| Williams %R | -11.1 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 118.8 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +14.3% | Change over 10 sessions | Bullish |
| ATR (14) | $10.34 | Typical daily range, 11.0% of price |
What happened before
See how TMDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TMDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
Whale Options Flow
90DNo whale options trades in TMDX in the last 90 days.
Dark Pool
30DTMDX Institutional Ownership
Full report →- ●181 buying vs 184 selling
- ▲Held by funds +4.0 pts
- ▲Funds holding +7
- ▼Superinvestors: 1 added, 2 cut
- ▲Put/call 7.06 to 3.46
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 384 | 377 | +1.9% |
| In funds' top 10 | 2 | 1 | +100.0% |
| Held by funds | 104.3% | 100.3% | +4.0 pts |
| New / increased | 58 / 123 | 64 / 139 | −10.8% |
| Reduced / sold out | 132 / 52 | 125 / 109 | −21.4% |
| Put/call ratio | 3.46 | 7.06 | −51.0% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMDX is in one of them and how their past TMDX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TMDX in an article yet. Here's the latest on the wider market.
TMDX Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Donald J TrumpExecutive branch | Sell | $15K – $50K | Jul 8, 2026 | Sep 22, 2026 | 76 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About TransMedics Group
TransMedics Group develops medical technology for organ transplants. Its Organ Care System is a portable device that keeps donor hearts, lungs and livers in a living state outside the body, using warm, oxygenated blood instead of cold storage. The company also runs a National OCS Program that handles organ procurement and aviation and ground transport for transplant centers across the United States. Its customers are mainly transplant centers and hospitals, and the company is based in Andover, Massachusetts.
- Headquarters
- Andover, MA



